By Molika Ashford

SQI Diagnostics said last week that it is restructuring its business and reducing its workforce by nearly a third. The company expects the realignment to bring more focus to its diagnostics tools and services business, while it streamlines its in vitro diagnostics development schedule.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.